|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1999-10-7
|
|
pubmed:abstractText |
One-week low-dose triple therapy is currently considered the gold standard regimen for treatment of Helicobacter pylori infection. However, the mechanisms involved in the synergy between antibiotics and proton pump inhibitors are controversial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
pubmed-author:BrandstätterGG,
pubmed-author:DragosicsBB,
pubmed-author:GschwantlerMM,
pubmed-author:HentschelEE,
pubmed-author:HirschlA MAM,
pubmed-author:KlimpfingerMM,
pubmed-author:OberhuberGG,
pubmed-author:PaschingEE,
pubmed-author:SchützeKK,
pubmed-author:WeissWW,
pubmed-author:WimmerMM,
pubmed-author:WurzerHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1063-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10468682-Adult,
pubmed-meshheading:10468682-Aged,
pubmed-meshheading:10468682-Anti-Bacterial Agents,
pubmed-meshheading:10468682-Anti-Ulcer Agents,
pubmed-meshheading:10468682-Clarithromycin,
pubmed-meshheading:10468682-Drug Combinations,
pubmed-meshheading:10468682-Drug Resistance, Microbial,
pubmed-meshheading:10468682-Famotidine,
pubmed-meshheading:10468682-Female,
pubmed-meshheading:10468682-Helicobacter Infections,
pubmed-meshheading:10468682-Helicobacter pylori,
pubmed-meshheading:10468682-Humans,
pubmed-meshheading:10468682-Male,
pubmed-meshheading:10468682-Metronidazole,
pubmed-meshheading:10468682-Microbial Sensitivity Tests,
pubmed-meshheading:10468682-Middle Aged,
pubmed-meshheading:10468682-Omeprazole,
pubmed-meshheading:10468682-Stomach Ulcer
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
|
|
pubmed:affiliation |
The 4th Department of Internal Medicine, KA Rudolfstiftung, Vienna, Austria. Michael.Gschwantler@kar.magwien.gv.at
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
